|
|
AMMONIO METHACRYLATE COPOLYMER TYPE B Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
ALGINIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
SODIUM METABISULFITE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
SODIUM POLYSTYRENE SULFONATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|